The vascular cambium, to use the term in the general sense as designation for the entire meristem producing secondary xylem and phloem, consists of the self-perpetuating uniseriate initiating layer and the derived tissue mother cells. In the dormant condition the cambium in the stems of mature trees is one to four, usually two to three, cells wide. The one to three tangential tiers of cells toward the xylem are made up of xylem mother cells, and the single tier next the phloem is composed of initial cells. On reactivation all cambial cells expand radially. Periclinal divisions soon follow, usually according to a sequence in which the xylem mother cells in the tier contiguous to the late wood are the first to divide and the initial cells last, although some variation occurs. The zone of periclinal division rapidly widens to 100-300 μ in vigorous open-grown trees, the center of activity during this vernal surge of growth clearly being among the dividing and redividing xylem mother cells. Thereafter, from mid-June to August, a continued decline in cell production follows as the zone of xylem mother cells decreases from many tangential rows to few. The initiating layer becomes relatively more important as the center of cell generation, and toward the end of the growing season the initial cells undergo those changes which modify the cellular pattern of the cambium and hence of the derived tissues. Phloem development begins later than that of xylem, and at the end of May the new phloem varies from none to four cells as compared with a xylemward production of 30-60 cells in vigorous trees. Phloem expansion continues at a more or less steady rate from June to the termination of cambial activity in August or early September. The annual phloem increments vary less in width than those of xylem.
In the gradual enlargement of tracheid dimensions which takes place outward from the pith in the stem and branches, growth in cell length outstrips that in tangential width so that the length/width ratio rises. Largest tracheids are usually found in the inner wood of lateral roots, where the length/width ratio is highest. Interspecific and interregional differences follow a similar pattern of relationship with respect to cell di~nensions. As a rule, species or races which inhabit unfavorable sites have con~paratively small cells with a low length/width ratio. Species which populate better sites and have greater growth potential are characterized by longer cells and a higher length/width ratio. Indications exist of a positive relationship between height growth, tracheid length, and the length/ width ratio. On the other hand, increased radial growth in mature trees is accompanied by reduction in mean cell length and a lowering of the length/width ratio.
The early growth of a tree is marked by a widening of the annual increments, a deceleration in rate of multiplicative (anticlinal) division of fusiform cambial cells, and an increase in cell length. Distance outward from the pith at which maximation in cell size occurs, and subsequent trends in cell dimensions, are apparently modified by rate of growth. Continuation of a uniform ring width through the middle to late years favors comparative constancy in rate of anticlinal division and cell size during that stage of tree development. Reduction in amount of annual increment in the late growth to the width optimal for cell extension, about 1 mm, induces a delayed and probably heightened maximation in cell length. Continued lessening in radial growth to an annual accretion of 0.5 mm or less, with the onset of senility, results in acceleration in rate of multiplicative division and reduction in cell length.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.